Priority Date: 24.03.11 (EP 20110305330)

DOMINANT NEGATIVE HSP110 MUTANT AND ITS USE IN PROGNOSING AND TREATING CANCERS

  • Application ID: EP12710730
  • Status: NO OPPOSITION FILED WITHIN TIMELIMIT

Attorneys

no operation time available
1080.54
2 offices
active in Legal Services
operating since 1999
Headquarter in Paris
active in Legal Services and IP Consulting

Specialization

This patent has the IPC combination C07, C12, and G01 is specialized in the combination C07, C12, and G01. We found, that TransMIT GmbH, Kailuweit & Uhlemann, dompatent von Kreisler Selting Werner - Partnerschaft von Patent- und Rechtsanwälten mbB, Kilburn & Strode LLP, Potter Clarkson LLP and 63 others are specialized in all of these IPC classes. For a similar patent, they might be a good choice.

Timeline

  • 24.03.2011 - Priority Date (EP 20110305330)
  • 27.09.2012 - Publication A1 (WO2012127062)
  • 29.01.2014 - Publication A1 (EP2688907)
  • 27.04.2016 - Publication B1 (EP2688907)